Efficient and Fast Generation of Relevant Disease Mouse Models by In Vitro and In Vivo Gene Editing of Zygotes

dc.contributor.authorSanchez-Baltasar, Raquel
dc.contributor.authorGarcia-Torralba, Aida
dc.contributor.authorNieto-Romero, Virginia
dc.contributor.authorPage, Angustias
dc.contributor.authorMolinos-Vicente, Andrea
dc.contributor.authorLópez-Manzaneda, Sergio
dc.contributor.authorOjeda-Pérez, Isabel
dc.contributor.authorRamírez, Ángel
dc.contributor.authorNavarro, Manuel
dc.contributor.authorSegovia, José Carlos
dc.contributor.authorGarcía-Bravo, María
dc.date.accessioned2024-02-06T14:23:34Z
dc.date.available2024-02-06T14:23:34Z
dc.date.issued2022-06
dc.description.abstractKnockout mice for human disease-causing genes provide valuable models in which new therapeutic approaches can be tested. Electroporation of genome editing tools into zygotes, in vitro or within oviducts, allows for the generation of targeted mutations in a shorter time. We have generated mouse models deficient in genes involved in metabolic rare diseases (Primary Hyperoxaluria Type 1 Pyruvate Kinase Deficiency) or in a tumor suppressor gene (Rasa1). Pairs of guide RNAs were designed to generate controlled deletions that led to the absence of protein. In vitro or in vivo ribonucleoprotein (RNP) electroporation rendered more than 90% and 30% edited newborn animals, respectively. Mice lines with edited alleles were established and disease hallmarks have been verified in the three models that showed a high consistency of results and validating RNP electroporation into zygotes as an efficient technique for disease modeling without the need to outsource to external facilities.es_ES
dc.description.sponsorshipThis work was supported by grants from “Ministerio de Economía, Comercio y Competitividad” (PID2020-119637RB-I00), Fondo de Investigaciones Sanitarias, “Instituto de Salud Carlos III” (RD21/0017/0027 and PI20/01173), and cofunded by the European Regional Development Fund (FEDER), “Comunidad de Madrid” (AvanCell, B2017/BMD-3692), and Oxalosis and Hyperoxaluria Foundation. The authors also received funds from Instituto de Investigación Sanitaria “Fundación Jiménez Díaz” and CIBERER (CB06/07/0014) and CIBERONC (CB16/12/00228), initiatives of the “Instituto de Salud Carlos III” and “Fondo Europeo de Desarrollo Regional (FEDER).” R.S.-B. is funded by the Consejería de Ciencia, Universidades e Innovación (Comunidad de Madrid), and the European Regional Development Fund (FEDER). “Ministerio de Ciencia, Innovación y Universidades” awarded grants to V.N.-R. (FPU16/02228), A.M.-V. (FPU17/02179), and I.O.-P. (SAF2017-84248-P).es_ES
dc.identifier.citationSanchez-Baltasar R, Garcia-Torralba A, Nieto-Romero V, Page A, Molinos-Vicente A, López-Manzaneda S, Ojeda-Pérez I, Ramirez A, Navarro M, Segovia JC, García-Bravo M. Efficient and Fast Generation of Relevant Disease Mouse Models by In Vitro and In Vivo Gene Editing of Zygotes. CRISPR J. 2022 Jun;5(3):422-434. doi: 10.1089/crispr.2022.0013. PMID: 35686982; PMCID: PMC9233508.es_ES
dc.identifier.doihttp://dx.doi.org/10.1089/crispr.2022.0013
dc.identifier.urihttps://hdl.handle.net/20.500.14855/2353
dc.language.isoenges_ES
dc.publisherCRISPR Journales_ES
dc.rights.accessRightsopen accesses_ES
dc.subjectgene editinges_ES
dc.subjectzygoteses_ES
dc.subjectprimary hyperoxaluriaes_ES
dc.subjectpyruvate kinase deficencyes_ES
dc.subjectRasa1es_ES
dc.subjectAgxt1es_ES
dc.subjectPklres_ES
dc.subjectmouse modelses_ES
dc.titleEfficient and Fast Generation of Relevant Disease Mouse Models by In Vitro and In Vivo Gene Editing of Zygoteses_ES
dc.typejournal articlees_ES

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
24. Sanchez-Baltasar- CRISPR J 2022.pdf
Size:
1.09 MB
Format:
Adobe Portable Document Format